Clinical Trial Update: Inhaled Loxapine vs Intramuscular (IM) Haloperidol + Lorazepam for Agitation [Phase 4]

View source ↗

Summary

Phase 4 trial comparing inhaled loxapine vs intramuscular haloperidol plus lorazepam for agitation was terminated, with results posted on 2018-06-11.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Agitation

Drugs mentioned

• Adasuve (inhaled loxapine) (loxapine)
• Haloperidol (IM) (haloperidol)
• Lorazepam (IM) (lorazepam)

Snippet

Sponsor: University of Arkansas | Conditions: Agitation,Psychomotor, Haloperidol Causing Adverse Effects in Therapeutic Use | Phase 4 | Status: TERMINATED | Results posted: 2018-06-11